GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Betta Pharmaceuticals Co Ltd (SZSE:300558) » Definitions » Margin of Safety % (DCF Dividends Based)

Betta Pharmaceuticals Co (SZSE:300558) Margin of Safety % (DCF Dividends Based) : -296.69% (As of Jun. 05, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Betta Pharmaceuticals Co Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

As of today (2024-06-05), Betta Pharmaceuticals Co's Predictability Rank is 3-Stars. Betta Pharmaceuticals Co's intrinsic value calculated from the Discounted Dividend model is ¥10.76 and current share price is ¥38.40. Consequently,

Betta Pharmaceuticals Co's Margin of Safety % (DCF Dividends Based) using Discounted Dividend model is -296.69%.

Competitive Comparison of Betta Pharmaceuticals Co's Margin of Safety % (DCF Dividends Based)

For the Drug Manufacturers - Specialty & Generic subindustry, Betta Pharmaceuticals Co's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Betta Pharmaceuticals Co's Margin of Safety % (DCF Dividends Based) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Betta Pharmaceuticals Co's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where Betta Pharmaceuticals Co's Margin of Safety % (DCF Dividends Based) falls into.


Betta Pharmaceuticals Co Margin of Safety % (DCF Dividends Based) Calculation

Betta Pharmaceuticals Co's Margin of Safety % (DCF Dividends Based) for today is calculated as

Margin of Safety % (DCF Dividends Based)=(Intrinsic Value: DCF (Dividends Based)-Current Price)/Intrinsic Value: DCF (Dividends Based)
=(9.68-38.40)/9.68
=-296.69 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted Dividend model with default parameters.

Betta Pharmaceuticals Co Margin of Safety % (DCF Dividends Based) Related Terms

Thank you for viewing the detailed overview of Betta Pharmaceuticals Co's Margin of Safety % (DCF Dividends Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Betta Pharmaceuticals Co (SZSE:300558) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Betta Pharmaceuticals Co Ltd (SZSE:300558) » Definitions » Margin of Safety % (DCF Dividends Based)
Comparable Companies
SHSE:600521 SHSE:600566 SHSE:600129 SHSE:600518 SHSE:688276 SHSE:600380 SZSE:002262 SHSE:600535 SHSE:600867 SHSE:603456 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
No.355, Xingzhong Road, Yuhang Economic and Technological Development Zone, Zhejiang Province, Hangzhou, CHN
Website
http://www.bettapharma.com
Betta Pharmaceuticals Co Ltd is a hi-tech pharmaceutical enterprise focuses on research and development of innovative medicines. The company's drug is used for various diseases such as malignant tumors, diabetes, and cardio-cerebrovascular disease. Further, it offers Icotinib hydrochloride, an orally administered small-molecule and a reversible tyrosine kinase inhibitor, which is used for the treatment of non-small-cell lung cancer. Geographically, the group operates through China.
Executives
Wang Jia Bing Directors, executives
Ding Lie Ming Directors, executives
Cai Wan Yu Executives

Betta Pharmaceuticals Co (SZSE:300558) Headlines

No Headlines